BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 858010)

  • 1. Aspirin at therapeutic concentrations does not affect 5-hydroxytryptamine uptake by platelets.
    Drummond AH; MacIntyre DE; Olverman HJ
    Br J Pharmacol; 1977 Apr; 59(4):661-2. PubMed ID: 858010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of aspirin on 5-hydroxytryptamine uptake and release by human platelets.
    Rendu F
    Br J Pharmacol; 1976 May; 57(1):149-51. PubMed ID: 1276534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin and dazoxiben as inhibitors of platelet behaviour: modification of their effects by agents that alter cAMP production.
    Sills T; Cowley AJ; Heptinstall S
    Thromb Res; 1986 Apr; 42(1):91-8. PubMed ID: 3010495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of halofenate--free acid on aggregation--the release reaction, coagulant activity, and lipid metabolism of human platelets.
    Huzoor-Akbar ; Ardlie NG
    Thromb Haemost; 1977 Oct; 38(3):612-9. PubMed ID: 579507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The actions of flupenthixol upon 5-hydroxytryptamine-induced aggregation and the uptake of 5-hydroxytryptamine and dopamine by human blood platelets.
    Boullin DJ; Grimes RP; Orr MW
    Br J Pharmacol; 1975 Dec; 55(4):555-7. PubMed ID: 2360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of various ginseng saponins on 5-hydroxytryptamine release and aggregation in human platelets.
    Kimura Y; Okuda H; Arichi S
    J Pharm Pharmacol; 1988 Dec; 40(12):838-43. PubMed ID: 2907575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of fenfluramine on 5-hydroxytryptamine uptake and release by rat blood platelets.
    Buczko W; De Gaetano G; Garattini S
    Br J Pharmacol; 1975 Apr; 53(4):563-8. PubMed ID: 1148499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of copper-aspirin complex on platelet aggregation.
    Shen ZQ; Chen ZH; Ma GY; Wang DC; Wu WL; Liu WP; Yang YK; Xiong HZ
    Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):358-62. PubMed ID: 10072923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of aspirin and indomethacin on the platelet contractile wave.
    Gerrard JM; White JG
    Am J Pathol; 1976 Mar; 82(3):513-26. PubMed ID: 1258974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin.
    Chakraborty K; Khan GA; Banerjee P; Ray U; Sinha AK
    Platelets; 2003; 14(7-8):421-7. PubMed ID: 14713511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endotoxin and dietary amines may increase plasma 5-hydroxytryptamine in the horse.
    Bailey SR; Cunningham FM; Elliott J
    Equine Vet J; 2000 Nov; 32(6):497-504. PubMed ID: 11093623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin inhibits collagen-induced platelet serotonin release, as measured by microbore high-performance liquid chromatography with electrochemical detection.
    Tsai TH; Tsai WJ; Chen CF
    J Chromatogr B Biomed Appl; 1995 Jul; 669(2):404-7. PubMed ID: 7581919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diacylglycerol overcomes aspirin inhibition of platelets: evidence for a necessary role for diacylglycerol accumulation in platelet activation.
    Werner MH; Senzel L; Bielawska A; Khan W; Hannun YA
    Mol Pharmacol; 1991 Apr; 39(4):547-56. PubMed ID: 2017154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibitory effects of ferriprotoporphyrin IX on platelet aggregation and release of serotonin.
    Essien EM
    Thromb Res; 1985 Dec; 40(5):609-22. PubMed ID: 4089831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The action of halofenate on platelet shape change and prostaglandin synthesis.
    Favis GR; Colman RW
    J Lab Clin Med; 1978 Jul; 92(1):45-52. PubMed ID: 659964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some characteristics of mouse platelet aggregation and a comparison of the activity of a range of compounds in mouse and human platelet-rich plasma in vitro.
    Nunn B
    Thromb Haemost; 1981 Feb; 45(1):1-5. PubMed ID: 7245119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naftidrofuryl inhibits the release of 5-hydroxytryptamine and platelet-derived growth factor from human platelets.
    Barradas MA; Jagroop IA; Mikhailidis DP
    Clin Chim Acta; 1994 Oct; 230(2):157-67. PubMed ID: 7834867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nicotine on platelet function.
    Pfueller SL; Burns P; Mak K; Firkin BG
    Haemostasis; 1988; 18(3):163-9. PubMed ID: 3181816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.